Wasman Jane
SEC CIK 1352455 · EDGAR
BoughtSold
Most active insiders at RIGL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ali-Jackson Kamil | Dir | — | $160.4K |
| 2 | MOOS WALTER H | Dir | — | $145.4K |
| 3 | Rojkjaer Lisa | EVP, Chief Medical Off | — | — |
| 4 | Santos David A | EVP, Chief Commercial Off | — | — |
| 5 | HANNAH ALISON L. | EVP, Chief Medical Off | — | — |
| 6 | Furey Raymond J. | EVP, GC, CCO, Corp Sec | — | — |
| 7 | Schorno Dean L | EVP, CFO | — | — |
| 8 | Frohlich Mark W | Dir | — | — |
| 9 | Wasman Jane | Dir | — | — |
| 10 | LAPOINTE ANTHONY GREGG | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 20:50 | 2026-05-15 | RIGL | RIGEL PHARMACEUTICALS INC | Wasman Jane | Dir | A - Grant | $0.00 | +5,750 | 18.2K | +46% | $0 | |
| 2026-01-09 | 2026-01-07 | SLS | SELLAS Life Sciences Group, Inc. | Wasman Jane | Dir | A - Grant | $0.00 | +50.0K | 92.9K | +117% | $0 | |
| 2025-06-02 | 2025-05-30 | SLS | SELLAS Life Sciences Group, Inc. | Wasman Jane | Dir | P - Purchase | $1.69 | +20.0K | 30.4K | +192% | +$33.8K | |
| D | 2025-05-28 | 2025-05-23 | RIGL | RIGEL PHARMACEUTICALS INC | Wasman Jane | Dir | A - Grant | $0.00 | +2,500 | 12.5K | +25% | $0 |
| D | 2025-01-14 | 2025-01-10 | SLS | SELLAS Life Sciences Group, Inc. | Wasman Jane | Dir | A - Grant | $0.00 | +12.5K | 22.9K | +120% | $0 |
| D | 2024-05-29 | 2024-05-25 | RIGL | RIGEL PHARMACEUTICALS INC | Wasman Jane | Dir | A - Grant | $0.00 | +25.0K | 100.0K | +33% | $0 |
| D | 2024-01-25 | 2024-01-22 | SLS | SELLAS Life Sciences Group, Inc. | Wasman Jane | Dir | A - Grant | $0.00 | +6,000 | 10.4K | +136% | $0 |
| D | 2023-07-12 | 2023-05-26 | RIGL | RIGEL PHARMACEUTICALS INC | Wasman Jane | Dir | A - Grant | $0.00 | +25.0K | 75.0K | +50% | $0 |
| D | 2023-02-03 | 2023-02-02 | SLS | SELLAS Life Sciences Group, Inc. | Wasman Jane | Dir | A - Grant | $0.00 | +2,500 | 4,400 | +132% | $0 |
| D | 2022-05-23 | 2022-05-20 | RIGL | RIGEL PHARMACEUTICALS INC | Wasman Jane | Dir | A - Grant | $0.00 | +25.0K | 50.0K | +100% | $0 |
| D | 2022-02-01 | 2022-01-31 | SLS | SELLAS Life Sciences Group, Inc. | Wasman Jane | Dir | A - Grant | $0.00 | +1,900 | 1,900 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations